154 related articles for article (PubMed ID: 15101042)
1. Parkin gene alterations in hepatocellular carcinoma.
Wang F; Denison S; Lai JP; Philips LA; Montoya D; Kock N; Schüle B; Klein C; Shridhar V; Roberts LR; Smith DI
Genes Chromosomes Cancer; 2004 Jun; 40(2):85-96. PubMed ID: 15101042
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the common fragile site gene Parkin in ovarian and other cancers.
Denison SR; Wang F; Becker NA; Schüle B; Kock N; Phillips LA; Klein C; Smith DI
Oncogene; 2003 Nov; 22(51):8370-8. PubMed ID: 14614460
[TBL] [Abstract][Full Text] [Related]
3. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.
Park SW; Ludes-Meyers J; Zimonjic DB; Durkin ME; Popescu NC; Aldaz CM
Br J Cancer; 2004 Aug; 91(4):753-9. PubMed ID: 15266310
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
Picchio MC; Martin ES; Cesari R; Calin GA; Yendamuri S; Kuroki T; Pentimalli F; Sarti M; Yoder K; Kaiser LR; Fishel R; Croce CM
Clin Cancer Res; 2004 Apr; 10(8):2720-4. PubMed ID: 15102676
[TBL] [Abstract][Full Text] [Related]
5. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
6. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the FHIT gene in human hepatocellular carcinoma.
Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
[TBL] [Abstract][Full Text] [Related]
9. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.
Cesari R; Martin ES; Calin GA; Pentimalli F; Bichi R; McAdams H; Trapasso F; Drusco A; Shimizu M; Masciullo V; D'Andrilli G; Scambia G; Picchio MC; Alder H; Godwin AK; Croce CM
Proc Natl Acad Sci U S A; 2003 May; 100(10):5956-61. PubMed ID: 12719539
[TBL] [Abstract][Full Text] [Related]
10. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
Park SJ; Jeong SY; Kim HJ
Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
[TBL] [Abstract][Full Text] [Related]
11. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
12. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.
Ng IO; Liang ZD; Cao L; Lee TK
Cancer Res; 2000 Dec; 60(23):6581-4. PubMed ID: 11118037
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
14. Parkin as a tumor suppressor gene for hepatocellular carcinoma.
Fujiwara M; Marusawa H; Wang HQ; Iwai A; Ikeuchi K; Imai Y; Kataoka A; Nukina N; Takahashi R; Chiba T
Oncogene; 2008 Oct; 27(46):6002-11. PubMed ID: 18574468
[TBL] [Abstract][Full Text] [Related]
15. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract][Full Text] [Related]
16. SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.
Zimonjic DB; Durkin ME; Keck-Waggoner CL; Park SW; Thorgeirsson SS; Popescu NC
Neoplasia; 2003; 5(5):390-6. PubMed ID: 14670176
[TBL] [Abstract][Full Text] [Related]
17. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
18. [Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis].
Guo SP; Wang L; Wang WL; Li QL; Wang WY; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):467-72. PubMed ID: 17069699
[TBL] [Abstract][Full Text] [Related]
19. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
[TBL] [Abstract][Full Text] [Related]
20. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.
Letessier A; Garrido-Urbani S; Ginestier C; Fournier G; Esterni B; Monville F; Adélaïde J; Geneix J; Xerri L; Dubreuil P; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M; Chaffanet M
Oncogene; 2007 Jan; 26(2):298-307. PubMed ID: 16819513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
